Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Acq. announced
Director departure
|
|
Aprea Therapeutics, Inc. (APRE)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/24/2023 |
3
| BIZZARI JEAN-PIERRE (Director) has filed a Form 3 on Aprea Therapeutics, Inc. |
| 05/08/2023 |
3
| Gruia Gabriela (Director) has filed a Form 3 on Aprea Therapeutics, Inc. |
| 01/30/2023 |
3
| Hamill John P. (SrVP/CFO/Prin. Fin &Acctg. Off) has filed a Form 3 on Aprea Therapeutics, Inc. |
| 05/26/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/26/2022 |
3
| Pamukcu Rifat (Director) has filed a Form 3 on Aprea Therapeutics, Inc. |
| 05/26/2022 |
3
| Gilad Oren (President) has filed a Form 3 on Aprea Therapeutics, Inc. |
| 05/26/2022 |
3
| Duey Marc (Director) has filed a Form 3 on Aprea Therapeutics, Inc. |
| 09/29/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/18/2020 |
3
| Wessels Gregory S. (SVP, Chief Commercial Officer) has filed a Form 3 on Aprea Therapeutics, Inc. |
| 06/29/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/29/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/02/2019 |
3
| KDev Investments AB (10% Owner) has filed a Form 3 on Aprea Therapeutics, Inc. |
| 10/02/2019 |
3
| 5AM Ventures IV, L.P. (10% Owner) has filed a Form 3 on Aprea Therapeutics, Inc. |
| 10/02/2019 |
3
| HealthCap VII, L.P. (10% Owner) has filed a Form 3 on Aprea Therapeutics, Inc. |
| 10/02/2019 |
3
| Redmile Group, LLC (10% Owner) has filed a Form 3 on Aprea Therapeutics, Inc. |
| 10/02/2019 |
3
| Christenson Johan (Director) has filed a Form 3 on Aprea Therapeutics, Inc. |
| 10/02/2019 |
3
| ROCKLAGE SCOTT M (Director) has filed a Form 3 on Aprea Therapeutics, Inc. |
| 10/02/2019 |
3
| Abrahmsen Lars B. (SVP, Chief Scientific Officer) has filed a Form 3 on Aprea Therapeutics, Inc. |
| 10/02/2019 |
3
| HENNEMAN JOHN B III (Director) has filed a Form 3 on Aprea Therapeutics, Inc. |
| 10/02/2019 |
3
| Attar Eyal C. (SVP, Chief Medical Officer) has filed a Form 3 on Aprea Therapeutics, Inc. |
| 10/02/2019 |
3
| Versant V Luxco S.a r.l. (10% Owner) has filed a Form 3 on Aprea Therapeutics, Inc. |
| 10/02/2019 |
3
| Magni Guido (Director) has filed a Form 3 on Aprea Therapeutics, Inc. |
| 10/02/2019 |
3
| Korbel Gregory Alan (VP of Business Dev't) has filed a Form 3 on Aprea Therapeutics, Inc. |
| 10/02/2019 |
3
| Hepple Jonathan (Director) has filed a Form 3 on Aprea Therapeutics, Inc. |
| 10/02/2019 |
3
| SCHADE CHRISTIAN S (President & CEO) has filed a Form 3 on Aprea Therapeutics, Inc. |
| 10/02/2019 |
3
| Seizinger Bernd R. (Director) has filed a Form 3 on Aprea Therapeutics, Inc. |
| 10/02/2019 |
3
| Coiante Scott M (SVP, CFO) has filed a Form 3 on Aprea Therapeutics, Inc. |
|
|